Vanguard Group Inc Titan Pharmaceuticals Inc Transaction History

Vanguard Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.77 - $22.8 $97 - $2,895	127 Added 0.16%	82,051 $63,000
Q3 2022 Nov 14, 2022	BUY	$0.53 - $22.6 $3,725 - $158,855	7,029 Added 9.39%	81,924 $88,000
Q2 2022 Aug 12, 2022	SELL	$0.38 - $0.94 $49,982 - $123,641	-131,533 Reduced 63.72%	74,895 $42,000
Q4 2021 Feb 14, 2022	SELL	$1.02 - $1.93 $272 - $515	-267 Reduced 0.13%	206,428 $210,000
Q3 2021 Nov 12, 2021	BUY	$1.87 - $2.57 $4,433 - $6,093	2,371 Added 1.16%	206,695 $386,000
Q2 2021 Aug 13, 2021	BUY	$2.24 - $2.9 $457,685 - $592,539	204,324 New	204,324 $531,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $52.8M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.